Bancel Stephane 4
4 · Moderna, Inc. · Filed Mar 3, 2025
Insider Transaction Report
Form 4
Moderna, Inc.MRNA
Bancel Stephane
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-03-01+357,065→ 357,065 totalExercise: $30.96From: 2026-03-01Exp: 2035-03-01→ Common Stock (357,065 underlying)
Holdings
- 5,493,897
Common Stock
- 6,564,880(indirect: See Footnote)
Common Stock
- 9,050,372(indirect: See Footnote)
Common Stock
Footnotes (3)
- [F1]These shares are owned directly by Boston Biotech Ventures, LLC ("Boston Biotech"). The reporting person is the majority equity unit holder and the sole managing member of Boston Biotech. The reporting person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose.
- [F2]These shares are owned directly by OCHA LLC ("OCHA"). The reporting person is the majority equity unit holder and the sole managing member of OCHA. The reporting person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose.
- [F3]25% of this option will vest and become exercisable on March 1, 2026 with the remainder vesting in twelve (12) equal quarterly installments thereafter.